ArticleClinical ophthalmology (Auckland, N.Z.)2026
Interventional Keratoconus Management: The Critical Imperative for Early Detection and Treatment.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Keratoconus is an under-diagnosed progressive ectatic degeneration of the cornea associated with significant negative impact on both visual function and quality of life. Historical treatments-including optical refractive correction and penetrating keratoplasty-have significant limitations, the most important of which is that they fail to alter the progressive nature of the disease in some or all of patients. Corneal cross-linking in conjunction with cessation of eye rubbing and mechanical stressors represents a paradigm change in keratoconus therapy that stabilizes the degenerative process and offers both improvement in structural and functional outcomes and long-term stability in both visual function and quality of life. The development of corneal cross-linking and the opportunity to halt keratoconus progression makes imperative the early identification and treatment of subclinical cases when cross-linking offers the greatest long-term benefit. The availability of a less invasive epithelium-on cross-linking option further underscores this imperative. In this perspective, we describe the challenges of detecting early keratoconus and advocate for collaborative partnership with the entire eye care community to implement new and emerging technologies to find patients who would benefit from cross-linking and facilitate early referral to corneal surgeons for definitive treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.